Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kenneth E Thummel

Showing results (1-10 of 159) with videos related to

Pageof 16
Sort By:
Pharmacogenetics|May 29, 2004
A genetic test for immunosuppressant dose selection?Kenneth E Thummel
Pharmacogenetics|September 30, 2003
Does the CYP3A5*3 polymorphism affect in vivo drug elimination?Kenneth E Thummel
The Journal of Clinical Investigation|November 3, 2007
Gut instincts: CYP3A4 and intestinal drug metabolismKenneth E Thummel
Drug Metabolism and Disposition: the Biological Fate of Chemicals|January 19, 2013
Drug metabolism and transport during pregnancy: how does drug disposition change during pregnancy and what are the mechanisms that cause such changes?Nina Isoherranen, Kenneth E Thummel
Methods in Molecular Biology (Clifton, N.J.)|February 14, 2014
Sources of interindividual variabilityKenneth E Thummel, Yvonne S Lin
Trends in Pharmacological Sciences|December 13, 2016
Implementing Precision Medicine: The Ethical ChallengesDiane M Korngiebel, Kenneth E Thummel, Wylie Burke
Pharmacogenetics and Genomics|November 17, 2006
Adding pharmacogenetics information to drug labels: lessons learnedSusanne B Haga, Kenneth E Thummel, Wylie Burke
Molecular Interventions|July 5, 2005
CYP3A probes can quantitatively predict the in vivo kinetics of other CYP3A substrates and can accurately assess CYP3A induction and inhibitionEvan D Kharasch, Kenneth E Thummel, Paul B Watkins
Genetics in Medicine : Official Journal of the American College of Medical Genetics|May 10, 2014
Genetic factors affecting statin concentrations and subsequent myopathy: a HuGENet systematic reviewWilliam J Canestaro, Melissa A Austin, Kenneth E Thummel
Drug Metabolism and Disposition: the Biological Fate of Chemicals|August 10, 2023
The Utility of Mixed Effects Models in the Evaluation of Complex Genomic Traits In VitroNathan Alade, Abhinav Nath, Nina Isoherranen, et al.
Pageof 16

Showing results (1-10 of 159) with videos related to

Sort By:
Pageof 16
Pharmacogenetics|May 29, 2004
A genetic test for immunosuppressant dose selection?Kenneth E Thummel
Pharmacogenetics|September 30, 2003
Does the CYP3A5*3 polymorphism affect in vivo drug elimination?Kenneth E Thummel
The Journal of Clinical Investigation|November 3, 2007
Gut instincts: CYP3A4 and intestinal drug metabolismKenneth E Thummel
Drug Metabolism and Disposition: the Biological Fate of Chemicals|January 19, 2013
Drug metabolism and transport during pregnancy: how does drug disposition change during pregnancy and what are the mechanisms that cause such changes?Nina Isoherranen, Kenneth E Thummel
Methods in Molecular Biology (Clifton, N.J.)|February 14, 2014
Sources of interindividual variabilityKenneth E Thummel, Yvonne S Lin
Trends in Pharmacological Sciences|December 13, 2016
Implementing Precision Medicine: The Ethical ChallengesDiane M Korngiebel, Kenneth E Thummel, Wylie Burke
Pharmacogenetics and Genomics|November 17, 2006
Adding pharmacogenetics information to drug labels: lessons learnedSusanne B Haga, Kenneth E Thummel, Wylie Burke
Molecular Interventions|July 5, 2005
CYP3A probes can quantitatively predict the in vivo kinetics of other CYP3A substrates and can accurately assess CYP3A induction and inhibitionEvan D Kharasch, Kenneth E Thummel, Paul B Watkins
Genetics in Medicine : Official Journal of the American College of Medical Genetics|May 10, 2014
Genetic factors affecting statin concentrations and subsequent myopathy: a HuGENet systematic reviewWilliam J Canestaro, Melissa A Austin, Kenneth E Thummel
Drug Metabolism and Disposition: the Biological Fate of Chemicals|August 10, 2023
The Utility of Mixed Effects Models in the Evaluation of Complex Genomic Traits In VitroNathan Alade, Abhinav Nath, Nina Isoherranen, et al.
Pageof 16